CoChat

Editorial Commentary: Surgical Therapy for Staphylococcus aureus Prosthetic Valve Endocarditis: Proceed With Caution (Caveat Emptor)

Karchmer, A. W., Bayer, A. S. · 2015 · Clinical Infectious Diseases

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

(See the Major Article by Chirouze et al on pages 741–9.) Embraced by treatment guidelines from various organizations (eg, the American Heart Association, the European Society of Cardiology), the role of surgery in the treatment of left-sided infective endocarditis (IE) has been expanding in recent decades. The generally accepted indications for surgical intervention are based almost entirely on observational studies, and in some instances on expert opinion. Recent studies utilizing large datasets of patients with native valve IE have used sophisticated analytic techniques to assess the benefits of surgical treatment of IE. These studies adjust for treatment selection bias (propensity for surgery), prognostic variables, and comorbidities, as well as survival bias expressed as the time of surgery. At least 2 of these investigations have demonstrated survival benefits of early valve surgery (EVS) in terms of mortality in hospital and/or at 6 months after surgery [1, 2]. Prosthetic valve infective endocarditis (PVIE) represents a special management category, given its distinct pathogenesis and severe complications, especially in early PVIE (ie, within 12 months after valve implantation). Current guidelines [3, 4] and some studies advocate aggressive surgical intervention for patients with early PVIE, particularly when caused by staphylococci or complicated by severe heart failure (New York Heart Association [NYHA] class III–IV), valve dehiscence, or paravalvular abscess. At large tertiary hospitals with cardiac surgical programs, surgical intervention occurs in 42%–49% of patients with PVIE [5, 6]. This is not unexpected given the above-mentioned severe complications, which are unlikely to respond to antimicrobial therapy alone [5, 7]. Nevertheless, Lalani et al [7] were unable to demonstrate reduced in-hospital or 1-year mortality with valve replacement compared with medical therapy for PVIE. Using data collected prospectively between 1 January 2000 and 31 December 2006 by the multicenter International Collaborative on Endocarditis–Prospective Cohort Study (ICE-PCS), these investigators examined mortality rates among 1025 patients with definite PVIE, 490 (47.8%) of whom underwent surgery during their index hospitalization. After controlling for therapy selection bias using the inverse probability of treatment weighting, a propensity variable, in regression models, EVS was associated with lower mortality during hospitalization and at 1 year. However, when controlling for both treatment selection, as well as for survivor bias by including surgery as a time-dependent variable in a Cox proportional hazards model, the survival benefit of EVS was lost.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/ciu877

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Cited by

See all 5

Metadata

Authors
Karchmer, A. W., & Bayer, A. S.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • University of California, Los Angeles (US)
Corresponding author
Karchmer, A. W.
Venue
Clinical Infectious Diseases
Published
2014-11-10
Volume
60
Issue
5
Pages
750-752
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2126698551
Cited by
5
References
16
Citations by year
2019: 2 · 2017: 1 · 2015: 2
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01 AI-039108-17, R01AI039108)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
Keywords
prosthetic valve endocarditis, Staphylococcus aureus, infective endocarditis surgery, mortality, treatment selection bias, paravalvular abscess, valve dehiscence, heart failure, surgical indications, antibiotic therapy, left-sided endocarditis, paravalvular leak
MeSH terms
Endocarditis, Female, Heart Valves, Humans, Male, Staphylococcal Infections, Prosthesis-Related Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Editorial Commentary: Surgical Therapy for Staphylococcus aureus Prosthetic Valve Endocarditis: Proceed With Caution (Caveat Emptor). https://app.cochat.ai/papers/10.1093/cid/ciu877
The paper
Karchmer, A. W., & Bayer, A. S. (2015). Editorial Commentary: Surgical Therapy for Staphylococcus aureus Prosthetic Valve Endocarditis: Proceed With Caution (Caveat Emptor). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu877

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.